Sanarus Technologies
FDA Cleared, minimally invasive alternative to surgery for breast tumors, thousands of successful cases, cancer trial results show promise yet still round A.
- Stage $500K in TTM Revenue
- Industry Medical Devices and Equipment
- Location Pleasanton, CA, USA
- Currency USD
- Founded May 2009
- Employees 10
- Website sanarus.com
Company Summary
Sanarus is in the business of Women’s Health committed to enhance the Standard of Care for breast tumors. Made in the USA, we are the inventor of breast cryotechnology devices offering physicians a procedure that improves their economics, is performed in an office setting and has a 97% patient satisfaction rate. Additionally, this offers patients a minimally-invasive alternative to surgery that halt tumors, avoids scarring and heals naturally.
Team
-
BJ HardmanCEO
Prior to forming Sanarus Technologies in 2009, Ms. Hardman's career included executive roles spanning biomedical devices, manufacturing and financial and consulting services with firms such as J&J, Argonaut Group, KPMG, Pointstar and GE Capital. MS in Business Management, Sloan Fellow at Stanford University
-
president
Previously MR. Story was an operating executive with private equity firm HGGC after founding an executive consulting firm focused on operational strategy and technology adoption. Prior experience as a technology executive in start-up, high growth and turn around environments. Double engineering degrees from U.C. Davis.
-
Board Member, Senior Advisor
Jim possesses over 30 years in global healthcare leadership experience with expertise in sales, marketing, business development, and finance. Jim is a former CEO, COO, and General Manager with significant experience with startups, mid-market, and Fortune 15 companies. He has broad-based P&L, Balance Sheet and M&A experience and, in his previous leadership roles, exhibited fiscal discipline and demonstrated leadership in all functional areas.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.